Fat embolism syndrome pathophysiology: Difference between revisions
Feham Tariq (talk | contribs) |
Feham Tariq (talk | contribs) |
||
Line 23: | Line 23: | ||
This theory attributes the clinical manifestations of FES to the pro inflammatory effect of fat emboli.<ref name="pmid16990064">{{cite journal| author=Husebye EE, Lyberg T, Røise O| title=Bone marrow fat in the circulation: clinical entities and pathophysiological mechanisms. | journal=Injury | year= 2006 | volume= 37 Suppl 4 | issue= | pages= S8-18 | pmid=16990064 | doi=10.1016/j.injury.2006.08.036 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16990064 }} </ref><ref name="pmid9686075">{{cite journal| author=Estèbe JP| title=[From fat emboli to fat embolism syndrome]. | journal=Ann Fr Anesth Reanim | year= 1997 | volume= 16 | issue= 2 | pages= 138-51 | pmid=9686075 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9686075 }} </ref><ref name="pmid7753543">{{cite journal| author=Hofmann S, Huemer G, Kratochwill C, Koller-Strametz J, Hopf R, Schlag G et al.| title=[Pathophysiology of fat embolisms in orthopedics and traumatology]. | journal=Orthopade | year= 1995 | volume= 24 | issue= 2 | pages= 84-93 | pmid=7753543 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7753543 }} </ref> | This theory attributes the clinical manifestations of FES to the pro inflammatory effect of fat emboli.<ref name="pmid16990064">{{cite journal| author=Husebye EE, Lyberg T, Røise O| title=Bone marrow fat in the circulation: clinical entities and pathophysiological mechanisms. | journal=Injury | year= 2006 | volume= 37 Suppl 4 | issue= | pages= S8-18 | pmid=16990064 | doi=10.1016/j.injury.2006.08.036 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16990064 }} </ref><ref name="pmid9686075">{{cite journal| author=Estèbe JP| title=[From fat emboli to fat embolism syndrome]. | journal=Ann Fr Anesth Reanim | year= 1997 | volume= 16 | issue= 2 | pages= 138-51 | pmid=9686075 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9686075 }} </ref><ref name="pmid7753543">{{cite journal| author=Hofmann S, Huemer G, Kratochwill C, Koller-Strametz J, Hopf R, Schlag G et al.| title=[Pathophysiology of fat embolisms in orthopedics and traumatology]. | journal=Orthopade | year= 1995 | volume= 24 | issue= 2 | pages= 84-93 | pmid=7753543 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7753543 }} </ref> | ||
* | * Tissue lipases break down the fat in the bone marrow, forming high levels of glycerol and toxic free fatty acids. | ||
* These intermediate products lead to end-organ dysfunction. | * These intermediate products lead to end-organ dysfunction. | ||
* In the lung, toxic injury to pneumocytes and pulmonary endothelial cells causes vasogenic and cytotoxic edema as well as hemorrhage. | * In the lung, toxic injury to pneumocytes and pulmonary endothelial cells causes vasogenic and cytotoxic edema as well as hemorrhage. | ||
* | * Acute lung injury or acute respiratory distress syndrome. results from damaged pulmonary endothelium that triggers a proinflammatory cytokine cascade. | ||
===Video=== | ===Video=== |
Revision as of 22:22, 22 February 2018
Fat embolism syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Fat embolism syndrome pathophysiology On the Web |
American Roentgen Ray Society Images of Fat embolism syndrome pathophysiology |
Risk calculators and risk factors for Fat embolism syndrome pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Feham Tariq, MD [2]
Overview
Pathophysiology
Two major theories have been described to explain the pathophysiology of fat embolism syndrome(FES):[1]
- Mechanical theory
- Biochemical theory
Mechanical theory:
The theory proposes that there is mechanical obstruction by fat cells from the bone marrow in the end-capillaries after trauma.
- Post traumatic insult, the fat cells travel via venous sinusoids to the capillaries.
- These cells have potent prothrombotic and proinflammatory potential.
- They trigger rapid aggregation of platelets and accelerated fibrin generation as they travel through the venous system, eventually lodging in the pulmonary arterial circulation.
- Pulmonary capillary obstruction leads to interstitial hemorrhage and edema, alveolar collapse, and reactive hypoxemic vasoconstriction.
- Massive fat emboli may also lead to macrovascular obstruction and shock.
- Fat cells may also enter the arterial circulation via a patent foramen ovale or directly through the pulmonary capillary bed, causing the characteristic neurological and dermatologic findings of FES
Biochemical theory:
This theory attributes the clinical manifestations of FES to the pro inflammatory effect of fat emboli.[2][3][4]
- Tissue lipases break down the fat in the bone marrow, forming high levels of glycerol and toxic free fatty acids.
- These intermediate products lead to end-organ dysfunction.
- In the lung, toxic injury to pneumocytes and pulmonary endothelial cells causes vasogenic and cytotoxic edema as well as hemorrhage.
- Acute lung injury or acute respiratory distress syndrome. results from damaged pulmonary endothelium that triggers a proinflammatory cytokine cascade.
Video
{{#ev:youtube|eeAQ2akVjL8}}
The pathogenesis of FES is not completely defined. It is thought to be caused by blockage of vessels from systemic embolization of fat globules. Echocardiographic reports have demonstrated echogenic material passing through the right atrium followed by increased pulmonary pressures and right heart pressures and subsequent paradoxical embolization of this material through a patent foramen ovale (PFO).
The fat induces a toxic, inflammatory reaction. This inflammatory reaction is thought to be related to the production of free fatty acids. Studies have shown that neutral fatty acids are not toxic , however, they are hydrolyzed over many hours to substances proven to cause ARDS in animal models. Not surprisingly, C-reactive protein is usually elevated in these patients. Levels of lipoprotein lipase, and free fatty acids (FFA) are noted in animal models.
Genetics
Gross pathology
Microscopic pathology
References
- ↑ Parisi DM, Koval K, Egol K (2002). "Fat embolism syndrome". Am J Orthop (Belle Mead NJ). 31 (9): 507–12. PMID 12650535.
- ↑ Husebye EE, Lyberg T, Røise O (2006). "Bone marrow fat in the circulation: clinical entities and pathophysiological mechanisms". Injury. 37 Suppl 4: S8–18. doi:10.1016/j.injury.2006.08.036. PMID 16990064.
- ↑ Estèbe JP (1997). "[From fat emboli to fat embolism syndrome]". Ann Fr Anesth Reanim. 16 (2): 138–51. PMID 9686075.
- ↑ Hofmann S, Huemer G, Kratochwill C, Koller-Strametz J, Hopf R, Schlag G; et al. (1995). "[Pathophysiology of fat embolisms in orthopedics and traumatology]". Orthopade. 24 (2): 84–93. PMID 7753543.